{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:40:22Z","timestamp":1794969622371,"version":"4.9.1"},"reference-count":203,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.vaccine.2013.09.029","type":"journal-article","created":{"date-parts":[[2013,9,21]],"date-time":"2013-09-21T08:32:31Z","timestamp":1379752351000},"page":"5321-5338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Vaccines against diseases transmitted from animals to humans: A one health paradigm"],"prefix":"10.1016","volume":"31","author":[{"given":"Thomas P.","family":"Monath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.09.029_bib0005","series-title":"Human\u2013animal medicine. Clinical approaches to zoonoses, toxicants, and other shared risks","first-page":"1","article-title":"The convergence of human and animal medicine","author":"Kahn","year":"2010"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0010","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3201\/eid1112.050997","article-title":"Host range and emerging and reemerging pathogens","volume":"11","author":"Woolhouse","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0015","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/10408410701647594","article-title":"The human\/animal interface: emergence and resurgence of zoonotic infectious diseases","volume":"33","author":"Greger","year":"2007","journal-title":"Crit Rev Microbiol"},{"issue":"January\u2013March (1)","key":"10.1016\/j.vaccine.2013.09.029_bib0020","volume":"45","year":"2009","journal-title":"Vet Ital"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0025","series-title":"People, pathogens and our planet: vol. 2. The economics of One Health","first-page":"1","year":"2012"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0030","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMsb1209510","article-title":"Research as a part of public health emergency response","volume":"368","author":"Lurie","year":"2013","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2013.09.029_bib0035","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/s11250-012-0209-y","article-title":"The multiple burdens of zoonotic disease and an Ecohealth approach to their assessment","volume":"44","author":"Grace","year":"2012","journal-title":"Trop Anim Health Prod"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0040","series-title":"One Health: A New Professional Imperative: AVMA One Health Initiative Task Force Report","author":"AVMA","year":"2008"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0045","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/507571","article-title":"FDA experience with medical countermeasures under the animal rule","author":"Aebersold","year":"2012","journal-title":"Adv Prev Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0050","first-page":"29","article-title":"Epidemiology of West Nile in Europe and in the Mediterranean Basin","volume":"4","author":"Calistri","year":"2010","journal-title":"Open Virol J"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1051\/vetres\/2010039","article-title":"West Nile virus and its emergence in the United States of America","volume":"41","author":"MurrayKO","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/vbz.2007.0137","article-title":"West Nile virus neuroinvasive disease incidence in the United States, 2002\u20132006","volume":"8","author":"Lindsey","year":"2008","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0070","unstructured":"Centers for Disease Control, Atlanta, GA. http:\/\/www.cdc.gov\/westnile\/resources\/pdfs\/cummulative\/99_2012_cummulativeHumanCases.pdf."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0075","unstructured":"Centers for Disease Control, Atlanta, GA. http:\/\/www.cdc.gov\/westnile\/resources\/pdfs\/cummulative\/99_2012_NeuroInvasive byYear.pdf."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0080","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3201\/eid1008.030879","article-title":"Long-term prognosis for clinical West Nile virus infection","volume":"10","author":"Labowitz Klee","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0085","unstructured":"US Department of Agriculture."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0090","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2746\/042516407X248476","article-title":"A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003","volume":"39","author":"Epp","year":"2007","journal-title":"Equine Vet J"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (Chimerivax\u2122-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0100","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0264-410X(98)00487-3","volume":"17","author":"Monath","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0105","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1471-4914(01)02048-2","article-title":"Yellow fever vector live-virus vaccines: West Nile vaccine development","volume":"7","author":"Arroyo","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0110","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax\u2122-West Nile live-attenuated vaccine: preclinical evaluation of safety, immunogenicity and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005013343254","article-title":"West Nile vaccine","volume":"1","author":"Monath","year":"2001","journal-title":"Curr Drugs Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0120","series-title":"Suppl. proc. 53rd annu. meet. Am. J. Trop. Med. Hyg.","article-title":"Efficacy of a live attenuated chimeric West Nile virus vaccine in horses against clinical disease following challenge with virulent West Nile virus, abstr. 2096","author":"Bowen","year":"2004"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0125","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/CVI.00249-07","article-title":"Comparative efficacies of three commercially available vaccines against West Nile (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model","volume":"14","author":"Seino","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0130","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant vaccine against West Nile virus","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0135","unstructured":"http:\/\/www.equinechronicle.com\/health\/ask-the-vet\/vaccination-update.html."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0140","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/vbz.2011.0796","article-title":"Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1","volume":"12","author":"Yeh","year":"2012","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2013.09.029_bib0160","doi-asserted-by":"crossref","first-page":"e1929","DOI":"10.1371\/journal.pntd.0001929","article-title":"Clinical manifestations of human Brucellosis: a systematic review and meta-analysis","volume":"6","author":"Dean","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0165","first-page":"867","article-title":"Human health benefits from livestock vaccination for brucellosis: case study","volume":"81","author":"Roth","year":"2003","journal-title":"Bull WHO"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2013.09.029_bib0170","doi-asserted-by":"crossref","first-page":"D40","DOI":"10.1016\/j.vaccine.2009.08.058","article-title":"Brucellosis: The Case for Live, Attenuated Vaccines","volume":"27","author":"Flicht","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0180","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prevetmed.2008.02.005","article-title":"Estimating herd prevalence of bovine brucellosis in 46 US states using slaughter surveillance","volume":"85","author":"Ebel","year":"2008","journal-title":"Prev Vet Med"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2013.09.029_bib0185","doi-asserted-by":"crossref","first-page":"F64","DOI":"10.1016\/j.vaccine.2010.03.055","article-title":"Vaccination strategies for managing brucellosis in Yellowstone basin","volume":"28","author":"Treanor","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11515-012-1196-0","article-title":"Progress in Brucella vaccine development","volume":"8","author":"Yang","year":"2013","journal-title":"Front Biol (Beijing)"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1471-2458-8-241","article-title":"Incidence of human brucellosis in a rural area in Western Greece after the implementation of a vaccination programme against animal brucellosis","volume":"8","author":"Jelastopulu","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0200","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/dna.2008.0790","article-title":"A combined DNA vaccine provides protective immunity against Mycobacterium bovis and Brucella abortus in cattle","volume":"28","author":"Hu","year":"2009","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0034-5288(02)00146-7","article-title":"Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis","volume":"74","author":"Olsen","year":"2003","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0215","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1017\/S0950268806007564","article-title":"Risk factors for sporadic Shiga toxin-producing Escherichia coli O157 infections in FoodNet sites, 1999\u20132000","volume":"135","author":"Voetsch","year":"2007","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0220","doi-asserted-by":"crossref","first-page":"658","DOI":"10.4315\/0362-028X-67.4.658","article-title":"Escherichia coli O157 prevalence and enumeration of aerobic bacteria, Enterobacteriaceae, and Escherichia coli O157 at various steps in commercial beef processing plants","volume":"67","author":"Arthur","year":"2004","journal-title":"J Food Prot"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0225","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4315\/0362-028X-73.6.1030","article-title":"Animal- and truckload-level associations between Escherichia coli O157:H7 in feces and on hides at harvest and contamination of preevisceration beef carcasses","volume":"73","author":"Jacob","year":"2010","journal-title":"J Food Prot"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0230","series-title":"Econiche\u00ae Escherichia coli O157 bacterial extract vaccine. Product Monograph","author":"Bioniche Food Safety Inc.","year":"2012"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0235","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/fpd.2009.0290","article-title":"Use of a siderophore receptor and porin proteins-based vaccine to control the burden of Escherichia coli O157:H7 in feedlot cattle","volume":"6","author":"Thomson","year":"2009","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0240","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4315\/0362-028X-72.4.866","article-title":"Effects of a siderophore receptor and porin proteins-based vaccination on fecal shedding of Esherichia coli O157:H7 in experimentally inoculated cattle","volume":"72","author":"Thornton","year":"2009","journal-title":"J Food Prot"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0245","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1089\/fpd.2012.1150","article-title":"An outcomes model to evaluate risks and benefits of Escherichia coli vaccination in beef cattle","volume":"9","author":"Hurd","year":"2012","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0250","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3201\/eid1203.050931","article-title":"Bartonella spp. in pets and effect on human health","volume":"12","author":"Chomel","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1756-3305-4-49","article-title":"One health: the importance of companion animal vector-borne diseases","volume":"4","author":"Day","year":"2011","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0260","series-title":"Arthropod-borne infectious diseases of the dog and cat","first-page":"110","article-title":"Bartonellosis","author":"Birtles","year":"2005"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0265","series-title":"Dogs, zoonoses and public health","first-page":"333","article-title":"Zoonoses Control in dogs","author":"Meslin","year":"2000"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0270","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5372\/1905-7415.0504.075","article-title":"How to eradicate canine rabies: a perspective of historical efforts","volume":"5","author":"Clifton","year":"2011","journal-title":"Asian Biomed"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0275","doi-asserted-by":"crossref","first-page":"S697","DOI":"10.1093\/clinids\/10.Supplement_4.S697","article-title":"Mass vaccination campaign against rabies: are dogs correctly protected? The Peruvian experience","volume":"Suppl. 4","author":"Chomel","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","author":"Hemachudha","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0285","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0290","series-title":"Global Vaccine Market Report","author":"Frost & Sullivan","year":"2009"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0295","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4269\/ajtmh.1998.58.835","article-title":"Field evaluation of a dog owner, participation-based, bait delivery system for the oral immunization of dogs against rabies in Tunesia","volume":"58","author":"Ben Youssef","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0300","series-title":"Field application of oral rabies vaccines for dogs","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0305","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","article-title":"Field trial with oral vaccination of dogs against rabies in the Philippines","volume":"1","author":"Estrada","year":"2001","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0310","first-page":"1","article-title":"Oral vaccination of foxes against rabies with SAD B19 in Europe, 1983\u20131998: a review","volume":"70","author":"Vos","year":"2000","journal-title":"Vet Bull"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0315","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.virusres.2005.03.017","article-title":"Oral vaccination of dogs with recombinant rabies virus vaccines","volume":"111","author":"Rupprecht","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1071\/NB12079","article-title":"One Health and Hendra virus: a collaborative approach in action","volume":"23","author":"Crawford","year":"2012","journal-title":"New South Wales Public Health Bull"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0325","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrmicro1323","article-title":"Hendra and Nipah viruses: different and dangerous","volume":"4","author":"Eaton","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0330","doi-asserted-by":"crossref","first-page":"946","DOI":"10.4269\/ajtmh.2011.10-0567","article-title":"Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission","volume":"85","author":"Halpin","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0335","first-page":"133","article-title":"Henipaviruses: emerging paramyxoviruses associated with fruit bats","volume":"315","author":"Field","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0340","unstructured":"CSIRO, Australia. http:\/\/www.csiro.au\/en\/Outcomes\/Food-and-Agriculture\/Hendra-Virus.aspx."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0345","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1177\/0300985810378648","article-title":"Henipavirus: a review of laboratory animal pathology","volume":"47","author":"Williamson","year":"2010","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0350","first-page":"N2","article-title":"Hendra vaccine success announced","volume":"89","author":"Balzer","year":"2011","journal-title":"Aust Vet J"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0355","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid1801.111006","article-title":"Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia","volume":"18","author":"Mendez","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0360","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1128\/JVI.79.11.6690-6702.2005","article-title":"Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus","volume":"79","author":"Bossart","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0365","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1016\/j.vaccine.2011.06.015","article-title":"A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge","volume":"29","author":"Pallister","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0370","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004241","article-title":"A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge","volume":"4","author":"Bossart","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0375","unstructured":"http:\/\/www.horseoz.com\/adelaide\/Horse_Industry_Events_Sponsors\/horse_industry_events_sponsors.html."},{"key":"10.1016\/j.vaccine.2013.09.029_bib0380","series-title":"Infectious diseases of livestock","article-title":"Rift Valley fever","author":"Swanepoel","year":"1994"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0385","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4269\/ajtmh.2010.09-0669","article-title":"Severe Rift Valley fever may present with a characteristic clinical syndrome","volume":"82","author":"Kahlon","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0390","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1086\/378747","article-title":"Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics","volume":"37","author":"Madani","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"Pepin","year":"2010","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0400","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S0022172400062434","article-title":"Rift Valley fever virus (family Bunyaviridae, genus Phlebovirus). Isolations from Diptera collected during an inter-epizootic period in Kenya","volume":"95","author":"Linthicum","year":"1985","journal-title":"J Hyg (Lond)"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0405","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.0806490106","article-title":"Prediction of a Rift Valley fever outbreak","volume":"106","author":"Anyamba","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0410","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"Bird","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0415","first-page":"1","article-title":"Rift Valley fever: the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0420","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of nonindigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0425","first-page":"45","article-title":"An inactivated Rift Valley fever vaccine","volume":"48","author":"Barnard","year":"1977","journal-title":"J S Afr Vet Assoc"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0430","first-page":"261","article-title":"The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO\/FAO meeting","volume":"61","author":"World Health Organization","year":"1983","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0435","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2157-7560.1000121","article-title":"ZH501-VSVRI: Is it still the best choice for vaccination against Rift Valley fever in Egypt?","volume":"2","author":"Atwa","year":"2011","journal-title":"J Vaccines Vaccin"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0440","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0445","first-page":"197","article-title":"Active and passive immunization against Rift Valley fever virus infection in Syrian hamsters","volume":"92","author":"Niklasson","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0450","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0455","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0465","series-title":"Factors in the emergence of arbovirus diseases","first-page":"253","article-title":"Emergence of Rift Valley fever","author":"Peters","year":"1997"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0470","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0475","first-page":"1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0480","first-page":"95","article-title":"Teratogenicity of a mutagenised Rift Valley fever virus (MVP12) in sheep","volume":"69","author":"Hunter","year":"2002","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0485","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0490","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"Bird","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0495","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0500","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0505","series-title":"Infectious diseases of livestock","first-page":"1037","article-title":"Rift Valley fever","author":"Swanepoel","year":"2004"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0510","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley fever clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0515","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"Wallace","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268808001696","article-title":"An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus","volume":"137","author":"Heise","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0525","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1016\/j.vaccine.2010.04.048","article-title":"Rift Valley fever virus immunity pro-vided by a paramyxovirus vaccine vector","volume":"28","author":"Kortekaas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0530","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2012.00131","article-title":"Novel approaches to develop Rift Valley fever vaccines","author":"Indran","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0535","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift Valley fever: recent insights into pathogenesis and prevention","volume":"85","author":"Boshra","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0540","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.virol.2008.12.012","article-title":"Vaccination with virus like particles protects mice from lethal infection of Rift Valley Fever Virus","volume":"385","author":"Naslund","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0545","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1016\/j.vaccine.2008.07.042","article-title":"Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep","volume":"26","author":"Lorenzo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0550","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2217\/fvl.11.50","article-title":"Endemic Venezuelan equine encephalitis in the Americas: Hidden under the dengue umbrella","volume":"6","author":"Aguilar","year":"2011","journal-title":"Future Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0555","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1073\/pnas.0509961103","article-title":"Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation","volume":"103","author":"Anishchenko","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0560","series-title":"Venezuelan encephalitis. Proceedings of the workshop \u2013 symposium on Venezuelan equine encephalitis","first-page":"7","article-title":"The health and economic impact of Venezuelaqn equine encephalitis (VEE)","author":"Groot","year":"1972"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0565","series-title":"Venezuelan encephalitis. Proceedings of the workshop \u2013 symposium on Venezuelan equine encephalitis","first-page":"369","article-title":"Inactivated and live VEE vaccines\u2014a review","author":"McKinney","year":"1972"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0570","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1086\/513978","article-title":"Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995","volume":"175","author":"Rivas","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0575","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(96)02275-1","article-title":"Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE Study Group","volume":"348","author":"Weaver","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0580","series-title":"Medical aspects of chemical and biological warfare. Textbook of military medicine, Part I","first-page":"561","article-title":"Viral encephalitides","author":"Smith","year":"1997"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0585","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells","volume":"74","author":"Berge","year":"1961","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0590","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0595","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0600","first-page":"351","article-title":"Immunization of burros with living Venezuelan equine encephalitis virus","volume":"75","author":"Gouchenour","year":"1962","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0605","first-page":"731","article-title":"Safety and efficacy of an attenuated VEE vaccine for use in equidae","volume":"159","author":"Spertzel","year":"1971","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0610","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/IAI.5.2.160-163.1972","article-title":"Field studies of an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83)","volume":"5","author":"Eddy","year":"1972","journal-title":"Infect Immun"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2013.09.029_bib0615","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0620","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0625","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.vaccine.2008.04.044","article-title":"Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates","volume":"26","author":"Fine","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0630","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0635","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.vaccine.2010.02.056","article-title":"Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus","volume":"28","author":"Martin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0640","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant Sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0645","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/IAI.72.9.5502-5505.2004","article-title":"Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine","volume":"72","author":"Mencher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0650","doi-asserted-by":"crossref","first-page":"738","DOI":"10.7589\/0090-3558-38.4.738","article-title":"Immune responses of bison to ballistic or hand vaccination with Brucella abortus strain RB51","volume":"38","author":"Olsen","year":"2002","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0655","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7589\/0090-3558-38.1.32","article-title":"A baiting system for delivery of an oral plague vaccine to black-tailed prairie dogs","volume":"38","author":"Creekmore","year":"2002","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0660","article-title":"Vaccination against Lyme disease","volume":"6","author":"Embers","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0665","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0670","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI21681","article-title":"The emergence of Lyme disease","volume":"113","author":"Steere","year":"2004","journal-title":"J Clin Invest"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.09.029_bib0675","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/cid\/ciq116","article-title":"Vaccines against Lyme disease: what happened and what lessons can we learn?","volume":"52","author":"Poland","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0680","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3201\/eid0503.990302","article-title":"The cost effectiveness of vaccinating against Lyme disease","volume":"5","author":"Meltzer","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0685","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0264-410X(96)00045-X","article-title":"Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine","volume":"14","author":"Ma","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0690","doi-asserted-by":"crossref","first-page":"713","DOI":"10.4065\/76.7.713","article-title":"Prevention of Lyme disease: a review of the evidence","volume":"76","author":"Poland","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2013.09.029_bib0695","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: the need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0700","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0705","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","article-title":"Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine","volume":"183","author":"de Silva","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0710","doi-asserted-by":"crossref","first-page":"18159","DOI":"10.1073\/pnas.0405763102","article-title":"An ecological approach to preventing human infection: vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle","volume":"101","author":"Tsao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0715","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1016\/j.vaccine.2005.08.089","article-title":"Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait","volume":"24","author":"Gomes-Solecki","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0720","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/CVI.05226-11","article-title":"Reservoir targeted vaccine for Lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice","volume":"18","author":"Richer","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0725","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.vaccine.2005.10.044","article-title":"Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs","volume":"24","author":"Scheckelhoff","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0730","doi-asserted-by":"crossref","first-page":"7818","DOI":"10.1016\/j.vaccine.2011.07.100","article-title":"Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease","volume":"29","author":"Bhattacharya","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0735","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tube.2005.05.002","article-title":"Human Mycobacterium bovis infection in the United Kingdom: incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis","volume":"86","author":"de la Rua-Domenech","year":"2006","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0740","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3201\/eid1703.101111","article-title":"Epidemiology of Mycobacterium bovis disease in humans, the Netherlands, 1993\u20132007","volume":"17","author":"Majoor","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0745","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3201\/eid0401.980108","article-title":"Zoonotic tuberculosis due to Mycobacterium bovis in developing countries","volume":"4","author":"Cosivi","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0750","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1051\/vetres\/2009033","article-title":"Classification of worldwide bovine tuberculosis risk factors in cattle: a stratified approach","volume":"40","author":"Humblet","year":"2009","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0755","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0074-02762005000500002","article-title":"BCG Moreau Rio de Janeiro\u2014an oral vaccine against tuberculosis\u2014review","volume":"100","author":"Ben\u00e9volo-de-Andrade","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0760","first-page":"874924","article-title":"Descriptive epidemiology of bovine tuberculosis in Michigan (1975\u20132010): lessons learned","volume":"2011","author":"Okator","year":"2011","journal-title":"Vet Med Int"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0765","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1051\/vetres:2007002","article-title":"Risk factors associated with the prevalence of tuberculosis-like lesions in fenced wild boar and red deer in south central Spain","volume":"38","author":"Vicente","year":"2007","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0770","doi-asserted-by":"crossref","first-page":"e39250","DOI":"10.1371\/journal.pone.0039250","article-title":"Comparing badger (Meles meles) management strategies for reducing tuberculosis incidence in cattle","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0775","first-page":"119","article-title":"The epidemiology of tuberculosis in free-ranging African buffalo (Syncerus caffer) in the Kruger National Park, South Africa","volume":"68","author":"De Vos","year":"2001","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0780","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/00480169.\/1995.35904","article-title":"Directions and issues in bovine tuberculosis epidemiology and control in New Zealand","volume":"43","author":"Morris","year":"1995","journal-title":"NZ Vet J"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0785","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2007.04.014","article-title":"A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection","volume":"25","author":"Collins","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0790","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1098\/rspb.2009.0414","article-title":"Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums","volume":"276","author":"Tompkins","year":"2009","journal-title":"Proc Biol Sci B"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0795","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7589\/0090-3558-45.3.754","article-title":"Lipid-formulated BCG as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy and palatability to New Zealand possums (Trichosurus vulpecula)","volume":"45","author":"Cross","year":"2009","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0800","series-title":"The red fox","first-page":"237","article-title":"Epidemiology of fox rabies","volume":"vol. 18","author":"Wandeler","year":"1980"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0805","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/oxfordjournals.aje.a121453","article-title":"The use of commercially available vaccines for the oral vaccination of foxes against rabies","volume":"96","author":"Debbie","year":"1972","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0810","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/oxfordjournals.aje.a121283","article-title":"Oral immunization of foxes against rabies","volume":"95","author":"Baer","year":"1971","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0815","series-title":"Wildlife rabies control","first-page":"82","article-title":"A review of the development of the oral vaccination technique for immunizing wildlife against rabies","author":"Winkler","year":"1992"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0820","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0147-9571(82)90031-5","article-title":"Oral immunization of foxes against rabies. Laboratory and field studies","volume":"5","author":"Steck","year":"1982","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0825","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2334-4-9","article-title":"Assessing anti-rabies baiting\u2014what happens on the ground?","volume":"4","author":"Thulke","year":"2004","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0830","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1439-0450.2004.00801.x","article-title":"Efficacy of oral vaccination in the final stage of fox rabies elimination in Switzerland","volume":"51","author":"Bugnon","year":"2004","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0835","first-page":"1","article-title":"WHO Expert Consultation on Rabies","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0840","series-title":"Contraception in wildlife management, Paper 17","first-page":"69","article-title":"A review of baits and bait delivery systems for free-ranging carnivores and ungulates","author":"Linhart","year":"1993"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0845","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0264-410X(94)90095-7","article-title":"Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern","volume":"12","author":"Lafay","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0850","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0065-3519(99)80043-3","article-title":"Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology","volume":"41","author":"Mackowiak","year":"1999","journal-title":"Adv Vet Med"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0855","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0860","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/317813a0","article-title":"Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype","volume":"317","author":"Buller","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0865","first-page":"417","article-title":"The oral rabies immunization of foxes and dogs with sausage baits","volume":"33","author":"Baer","year":"1976","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0870","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-1135(93)90083-J","article-title":"Efficacy of three oral rabies vaccine baits in the red fox: a comparison","volume":"38","author":"Artois","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1751-0147-45-1","article-title":"Arctic rabies \u2013 a review","volume":"45","author":"M\u03a6rk","year":"2004","journal-title":"Acta Vet Scand"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0880","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7589\/0090-3558-43.1.124","article-title":"Rabies challenge of captive striped skunks (Mephitis mephitis) following oral administration of a live vaccinia-vectored rabies vaccine","volume":"43","author":"Grosenbaugh","year":"2007","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0885","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1371\/journal.pntd.0000549","article-title":"Oral rabies vaccination in North America: opportunities, complexities, and challenges","volume":"3","author":"Slate","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0890","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2460\/javma.231.4.540","article-title":"Rabies surveillance in the United States during 2006","volume":"231","author":"Blanton","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0895","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/smvy.1994.1016","article-title":"Raccoon rabies: the re-emergence of an epizootic in a densely populated area","volume":"5","author":"Rupprecht","year":"1994","journal-title":"Semin Virol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0900","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2172-9-57","article-title":"Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization","volume":"9","author":"Root","year":"2008","journal-title":"BMC Immunol"},{"issue":"August","key":"10.1016\/j.vaccine.2013.09.029_bib0905","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3201\/eid1508.081061","article-title":"Tactics and economics of wildlife oral rabies vaccination, Canada and the United States","volume":"15","author":"Sterner","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0910","series-title":"Proc. 3rd NWRC special symposium \u2013 human conflicts with wildlife: economic considerations","first-page":"109","article-title":"Economic analysis of a large scale oral vaccination program to control raccoon rabies","author":"Kemere","year":"2002"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0915","doi-asserted-by":"crossref","first-page":"e1002786","DOI":"10.1371\/journal.ppat.1002786","article-title":"Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001\u20132009","volume":"8","author":"Kuzmin","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0920","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0264-410X(96)00012-6","article-title":"Human adenovirus type 5 vectors expressing rabies glycoprotein","volume":"14","author":"Yarosh","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0925","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7589\/0090-3558-45.2.363","article-title":"Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada","volume":"45","author":"Rosatte","year":"2009","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0930","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7589\/0090-3558-47.2.459","article-title":"High-density baiting with ONRAB\u00ae rabies vaccine baits to control arctic-variant rabies in striped skunks in Ontario, Canada","volume":"47","author":"Rosatte","year":"2011","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0935","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.actatropica.2005.04.012","article-title":"Effect of irrigated rice agriculture on Japanese encephalitis, including challenges and opportunities for integrated vector management","volume":"95","author":"Keiser","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0940","first-page":"21","article-title":"Disorder of spermatogenesis and viral discharge into semen in boars infected with Japanese encephalitis virus","volume":"27","author":"Habu","year":"1977","journal-title":"Virus"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0945","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4269\/ajtmh.2012.12-0315","article-title":"Occurrence of Japanese encephalitis virus mosquito vectors in relation to urban pig holdings","volume":"87","author":"Lindahl","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0950","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/248418","article-title":"Q fever: current state of knowledge and perspectives of research of a neglected zoonosis","author":"Porter","year":"2011","journal-title":"Int J Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268810002268","article-title":"The Q fever epidemic in the Netherlands: history, onset, response and reflection","volume":"139","author":"Roest","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0960","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.vetmic.2009.07.016","article-title":"Q fever","volume":"140","author":"Angelakis","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0965","first-page":"59","article-title":"Pr\u00e9vention de l\u2019excr\u00e9tion de Coxiella burnetii \u00e0 l\u2019aide d\u2019un vaccin phase I (Coxevac en troupeaux bovines laitiers infect\u00e9s)","volume":"15","author":"Guatteo","year":"2008","journal-title":"Rencontres Recherches Rumin"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0970","doi-asserted-by":"crossref","first-page":"704","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","article-title":"Vaccine prophylaxis of Q fever\u2014a follow-up study of the efficacy of Q-Vax (CSL) 1985\u20131990","volume":"160","author":"Ackland","year":"1994","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0975","series-title":"Q fever, vol. I. The disease","first-page":"225","article-title":"Prevention of Coxiella bumetii infection: vaccines and guidelines for those at risk","author":"Ormsbee","year":"1990"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0980","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/AEM.05530-11","article-title":"Four-year evaluation of the effect of vaccination against Coxiella burnetii on reduction of animal infection and environmental contamination in a naturally infected dairy sheep flock","volume":"77","author":"Astobiza","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0985","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/sj.clpt.6100391","article-title":"The importance of including swine and poultry workers in influenza vaccination programs","volume":"8","author":"Gray","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0990","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3201\/eid1303.060391","article-title":"Human and animal vaccination delivery to remote nomadic families, Chad","volume":"13","author":"Schelling","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib0995","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7589\/0090-3558-37.2.265","article-title":"Emergency response to raccoon rabies introduction into Ontario","volume":"37","author":"Rosatte","year":"2001","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2013.09.029_bib1000","first-page":"25","article-title":"How the research-based industry approaches vaccine development and establishes priorities","volume":"110","author":"Andre","year":"2002","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2013.09.029_bib1005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/CMR.00005-07","article-title":"Current status of veterinary vaccines","volume":"20","author":"Meeusen","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2013.09.029_bib1010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2105\/AJPH.2005.074583","article-title":"Assembling a global vaccine development pipeline for infectious diseases in the developing world","volume":"96","author":"Serdobova","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2013.09.029_bib1015","unstructured":"http:\/\/www.galvmed.org."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:23:33Z","timestamp":1715981013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1301270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":203,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0264410X1301270X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.029","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718119281.793486681","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines against diseases transmitted from animals to humans: A one health paradigm","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}